These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17896737)

  • 21. Ethical problems with neonatal screening.
    Orzalesi M; Danhaive O
    Ann Ist Super Sanita; 2009; 45(3):325-30. PubMed ID: 19861738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mandatory versus voluntary consent for newborn screening?
    Ross LF
    Kennedy Inst Ethics J; 2010 Dec; 20(4):299-328. PubMed ID: 21338027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next generation sequencing as a follow-up test in an expanded newborn screening programme.
    Smon A; Repic Lampret B; Groselj U; Zerjav Tansek M; Kovac J; Perko D; Bertok S; Battelino T; Trebusak Podkrajsek K
    Clin Biochem; 2018 Feb; 52():48-55. PubMed ID: 29111448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The modern face of newborn screening.
    Chien YH; Hwu WL
    Pediatr Neonatol; 2023 Feb; 64 Suppl 1():S22-S29. PubMed ID: 36481189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges for Worldwide Harmonization of Newborn Screening Programs.
    Martínez-Morillo E; Prieto García B; Álvarez Menéndez FV
    Clin Chem; 2016 May; 62(5):689-98. PubMed ID: 27001491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complex promise of newborn screening.
    Miller FA
    Indian J Med Ethics; 2009; 6(3):142-8. PubMed ID: 19653590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newborn screening of inherited metabolic disorders: the Italian situation.
    Focardi M; Pinchi V; Defraia B; Gualco B; Varvara G; Norelli GA
    J Biol Regul Homeost Agents; 2016; 30(3):909-914. PubMed ID: 27655520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening.
    Hinton CF; Grant AM; Grosse SD
    Ethn Health; 2011; 16(4-5):377-88. PubMed ID: 21797724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newborn Screening for Pompe Disease.
    Bodamer OA; Scott CR; Giugliani R;
    Pediatrics; 2017 Jul; 140(Suppl 1):S4-S13. PubMed ID: 29162673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How longitudinal observational studies can guide screening strategy for rare diseases.
    Mütze U; Mengler K; Boy N; Gleich F; Opladen T; Garbade SF; Kölker S
    J Inherit Metab Dis; 2022 Sep; 45(5):889-901. PubMed ID: 35488475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanded newborn screening by mass spectrometry: New tests, future perspectives.
    Ombrone D; Giocaliere E; Forni G; Malvagia S; la Marca G
    Mass Spectrom Rev; 2016; 35(1):71-84. PubMed ID: 25952022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model.
    Cipriano LE; Rupar CA; Zaric GS
    Value Health; 2007; 10(2):83-97. PubMed ID: 17391418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethical issues in newborn screening and the impact of new technologies.
    Wilcken B
    Eur J Pediatr; 2003 Dec; 162 Suppl 1():S62-6. PubMed ID: 14618395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canada: public health genomics.
    Little J; Potter B; Allanson J; Caulfield T; Carroll JC; Wilson B
    Public Health Genomics; 2009; 12(2):112-20. PubMed ID: 19039255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding newborn screening system issues with emphasis on cystic fibrosis screening.
    Therrell BL; Lloyd-Puryear MA; Mann MY
    J Pediatr; 2005 Sep; 147(3 Suppl):S6-10. PubMed ID: 16202785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn screening: what pediatricians should know.
    Leão LL; Aguiar MJ
    J Pediatr (Rio J); 2008 Aug; 84(4 Suppl):S80-90. PubMed ID: 18830514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethical issues in cystic fibrosis newborn screening: from data to public health policy.
    Wilfond B; Rothenberg LS
    Curr Opin Pulm Med; 2002 Nov; 8(6):529-34. PubMed ID: 12394162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First experience with a fully automated extraction system for simultaneous on-line direct tandem mass spectrometric analysis of amino acids and (acyl-)carnitines in a newborn screening setting.
    Fingerhut R; Silva Polanco ML; Silva Arevalo Gde J; Swiderska MA
    Rapid Commun Mass Spectrom; 2014 Apr; 28(8):965-73. PubMed ID: 24623702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethical aspects of the expansion of neonatal screening programme due to technological advances.
    Elliman D
    Clin Chem Lab Med; 2012 Jun; 50(6):999-1002. PubMed ID: 22035141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newborn screening policy and practice issues for nurses.
    Tluczek A; De Luca JM
    J Obstet Gynecol Neonatal Nurs; 2013; 42(6):718-29. PubMed ID: 24641079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.